Ferguson Wellman Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.87M Sell
14,789
-538
-4% -$70.9K 0.02% 183
2026
Q1
$2.14M Sell
15,327
-39
-0.3% -$5.46K 0.03% 165
2025
Q4
$1.89M Sell
15,366
-610
-4% -$74.1K 0.03% 142
2025
Q3
$1.77M Buy
15,976
+45
+0.3% +$5.12K 0.03% 147
2025
Q2
$1.77M Buy
15,931
+2,730
+21% +$291K 0.03% 146
2025
Q1
$1.48M Buy
13,201
+9,061
+219% +$935K 0.03% 156
2024
Q4
$382K Sell
4,140
-854
-17% -$76.9K 0.01% 272
2024
Q3
$419K Sell
4,994
-432
-8% -$33K 0.01% 271
2024
Q2
$372K Sell
5,426
-83,184
-94% -$5.55M 0.01% 278
2024
Q1
$6.49M Sell
88,610
-17,839
-17% -$1.37M 0.13% 85
2023
Q4
$8.62M Buy
106,449
+627
+0.6% +$48.8K 0.19% 78
2023
Q3
$7.93M Sell
105,822
-166,358
-61% -$12.8M 0.19% 82
2023
Q2
$21M Buy
272,180
+265,943
+4,264% +$21.2M 0.49% 59
2023
Q1
$517K Sell
6,237
-80
-1% -$6.63K 0.01% 251
2022
Q4
$542K Sell
6,317
-823
-12% -$65.2K 0.01% 244
2022
Q3
$440K Hold
7,140
0.02% 229
2022
Q2
$441K Sell
7,140
-300
-4% -$18.6K 0.02% 236
2022
Q1
$442K Sell
7,440
-1,325
-15% -$84.7K 0.01% 251
2021
Q4
$636K Buy
8,765
+223
+3% +$15.4K 0.02% 220
2021
Q3
$597K Sell
8,542
-33
-0.4% -$2.32K 0.02% 226
2021
Q2
$590K Sell
8,575
-576
-6% -$38.5K 0.02% 224
2021
Q1
$591K Sell
9,151
-2,675
-23% -$172K 0.02% 220
2020
Q4
$689K Sell
11,826
-1,205
-9% -$72.7K 0.02% 252
2020
Q3
$823K Sell
13,031
-4,373
-25% -$303K 0.02% 221
2020
Q2
$1.34M Sell
17,404
-3,478
-17% -$267K 0.04% 179
2020
Q1
$1.56M Sell
20,882
-255,958
-92% -$17.7M 0.06% 163
2019
Q4
$18M Sell
276,840
-25,775
-9% -$1.68M 0.53% 56
2019
Q3
$19.2M Buy
302,615
+6,475
+2% +$423K 0.61% 51
2019
Q2
$20M Buy
296,140
+17,765
+6% +$1.17M 0.66% 51
2019
Q1
$18.1M Sell
278,375
-82,838
-23% -$5.51M 0.62% 51
2018
Q4
$22.6M Buy
361,213
+52,660
+17% +$3.68M 0.87% 31
2018
Q3
$23.8M Buy
308,553
+105,818
+52% +$7.99M 0.78% 37
2018
Q2
$14.4M Buy
202,735
+167,280
+472% +$11.8M 0.5% 57
2018
Q1
$2.67M Sell
35,455
-4,410
-11% -$351K 0.09% 156
2017
Q4
$2.86M Sell
39,865
-1,727
-4% -$131K 0.1% 150
2017
Q3
$3.37M Sell
41,592
-2,610
-6% -$200K 0.12% 136
2017
Q2
$3.13M Sell
44,202
-5,127
-10% -$341K 0.12% 137
2017
Q1
$3.35M Sell
49,329
-3,707
-7% -$261K 0.13% 136
2016
Q4
$3.8M Sell
53,036
-10,079
-16% -$749K 0.15% 126
2016
Q3
$4.99M Sell
63,115
-236,658
-79% -$19.2M 0.21% 109
2016
Q2
$25M Sell
299,773
-131,036
-30% -$11.6M 1.05% 30
2016
Q1
$39.6M Buy
430,809
+31,591
+8% +$2.85M 1.68% 10
2015
Q4
$40.4M Buy
399,218
+9,434
+2% +$982K 1.66% 9
2015
Q3
$38.3M Buy
389,784
+5,445
+1% +$605K 1.7% 10
2015
Q2
$45M Buy
384,339
+1,698
+0.4% +$186K 1.86% 6
2015
Q1
$37.5M Sell
382,641
-121,115
-24% -$12.3M 1.55% 12
2014
Q4
$47.5M Buy
503,756
+11,810
+2% +$1.22M 1.91% 5
2014
Q3
$52.4M Buy
491,946
+3,825
+0.8% +$375K 2.23% 2
2014
Q2
$40.5M Buy
488,121
+6,595
+1% +$513K 1.71% 8
2014
Q1
$34.1M Buy
481,526
+93,045
+24% +$7.3M 1.52% 18
2013
Q4
$29.2M Buy
388,481
+5,285
+1% +$368K 1.32% 20
2013
Q3
$24.1M Buy
383,196
+14,381
+4% +$859K 1.19% 29
2013
Q2
$18.9M Buy
+368,815
New +$19.2M 1.46% 29

Other funds holding GILD

Ferguson Wellman Capital Management's GILD Position: Q2 2026 in Review

Ferguson Wellman Capital Management reduced its Gilead Sciences (GILD) stake by 3.5% in Q2 2026, selling an estimated $70.9K and leaving 14,789 shares worth $1.87M. The position accounts for 0.02% of the portfolio, ranked #183.

Ferguson Wellman Capital Management first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $52.4M in Q3 2014. 750 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Ferguson Wellman Capital Management held 14,789 shares of Gilead Sciences worth $1.87M as of Q2 2026.
  • Ferguson Wellman Capital Management sold 538 Gilead Sciences shares in Q2 2026, an estimated $70.9K.
  • Gilead Sciences made up 0.02% of Ferguson Wellman Capital Management's portfolio in Q2 2026, its #183 holding.
  • Ferguson Wellman Capital Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Ferguson Wellman Capital Management's Gilead Sciences position peaked at $52.4M in Q3 2014.
  • 750 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Ferguson Wellman Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.